European Medicines Agency 27d ago

What does the future of medicines regulation look like in the age of AI and big data? In this conversation, Prof. Dr. Karl Broich, President of BfArM, and Dr. Peter Arlett, Head of the Data Analytics and Methods Task Force at the European Medicines Agency, discuss how emerging technologies and new data sources are shaping the future of regulatory science in Europe. From artificial intelligence and real-world data to the European Health Data Space, they explore the opportunities, challenges, and practical implications of a more data-driven approach to medicines regulation, sharing insights into how innovation can support better decision-making and ultimately benefit public health. Watch to hear their perspectives on the future of medicines regulation in a rapidly evolving digital landscape. https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/artificial-intelligence